Skip to main content
Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication
MINUTES OF PROCEEDINGS
 
Meeting No. 28
 
Tuesday, November 21, 2006
 

The Standing Committee on Health met at 3:34 p.m. this day, in Room 371, West Block, the Chair, Rob Merrifield, presiding.

 

Members of the Committee present: Dave Batters, Hon. Carolyn Bennett, Patricia Davidson, Nicole Demers, Ruby Dhalla, Steven John Fletcher, Hon. Hedy Fry, Christiane Gagnon, Tina Keeper, Rob Merrifield and Penny Priddy.

 

Acting Members present: Joe Preston for Rick Dykstra.

 

In attendance: Library of Parliament: Sonya Norris, Analyst; Nancy Miller Chenier, Analyst; Odette Madore, Analyst.

 

Witnesses: Department of Health: Supriya Sharma, Associate Director General, Therapeutic Products Directorate, Health Products and Food Branch; Mary-Jane Bell, Head, Musculoskeletal Devices, Medical Devices Division, Therapeutic Products Directorate.

 
Pursuant to Standing Order 108(2) and the motion adopted by the Committee on Thursday, May 11, 2006, the Committee resumed its study of silicone gel-filled breast implants.
 

Supriya Sharma made a statement and, with the other witness, answered questions.

 

Nicole Demers moved, — That the Chair of the Committee report to the House of Commons the following motion that was adopted at the meeting on October 31, 2006:

That, following Health Canada’s decision to grant licences to Mentor and Inamed to once again market their silicone gel-filled breast implants, the Committee requests that:

- Health Canada officials appear before the Committee to explain their decision;

- the Committee obtain all of the studies or research that Health Canada considered in making its decision;

- and lastly, that the Committee receive a list of all the researchers who were consulted or whose studies were taken into consideration.

 

After debate, the question was put on the motion and it was agreed to on the following recorded division: YEAS: Carolyn Bennett, Nicole Demers, Ruby Dhalla, Hedy Fry, Christiane Gagnon, Tina Keeper, Penny Priddy — 7; NAYS: Dave Batters, Patricia Davidson, Steven John Fletcher, Joe Preston — 4.

 

Steven John Fletcher moved, — That the Committee append to its report a dissenting opinion from members of the Conservative Party provided that it is no more than one page in length and submitted electronically to the Clerk of the Committee, in both official languages, no later than Tuesday, November 28, 2006.

Debate arose thereon.

 

After debate, the question was put on the motion and it was agreed to.

 
At 4:45 p.m., the sitting was suspended.
 

At 4:51 p.m., the Committee proceeded to sit in camera.

 
The Committee proceeded to the consideration of matters related to Committee business.
 

The Chair presented the First Report from the Subcommittee on Agenda and Procedure which read as follows:

Your Subcommittee met on Thursday, November 2, 2006, to consider the business of the Committee and agreed to make the following recommendations:

1. That the following three items of business, referred to the Committee by the House of Commons be studied, before the last sitting day in December:

  • the Assisted Human Reproduction Regulations (referred on October 27 – deadline for consideration is January 29, 2007);

  • the Supplementary Estimates (A) for the fiscal year ending March 31, 2007 (referred on October 30 – deadline for consideration is December 4, 2006 (approx.));

  • if possible, Bill S-2, An Act to amend the Hazardous Materials Information Review Act (referred on November 1, 2006).

2. That the summary document of key issues prepared by the analysts for the study on Childhood Obesity be discussed in Committee, along with consideration of possible additional meetings, as well as the drafting of a report.

3. That Health Canada officials appear before the Committee on Tuesday, November 21, 2006, in order to explain the decision to once again market silicone gel-filled breast implants.

4. That the terms of reference for the study on Prescription Drugs be discussed at the meeting scheduled for Tuesday, November 21, 2006, and that in preparation for the meeting, members of the Committee be invited to submit their list of priorities for the study as soon as possible.

5. That the Minister of Health be invited to appear before the Committee on Thursday, November 23, 2006, on the Supplementary Estimates (A) for the fiscal year ending March 31, 2007.
 

It was agreed, — That the Clerk be authorized to make the editorial changes previously mentioned by the Chair, without changing the substance of the report.

 

On motion of Ruby Dhalla, it was agreed, — That the First Report of the Subcommittee on Agenda and Procedure be adopted, as amended.

 
Pursuant to Standing Order 108(2), the Committee resumed its study on Childhood Obesity.
 

The Committee commenced consideration of a document entitled Childhood Obesity: Summary of Key Issues.

 

At 5:34 p.m., the Committee adjourned to the call of the Chair.

 



Carmen DePape
Clerk of the Committee

 
 
2007/10/19 2:02 p.m.